Company Filing History:
Years Active: 2020-2024
Title: Harri Lähdesmäki: Innovator in Diabetes Risk Prediction
Introduction
Harri Lähdesmäki is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of medical diagnostics, particularly in predicting the risk of type-1 diabetes. With a total of 2 patents to his name, Lähdesmäki's work is paving the way for advancements in healthcare.
Latest Patents
Lähdesmäki's latest patents focus on innovative methods for determining the risk of type-1 diabetes through serum protein biomarkers. The first patent describes methods for predicting the risk of a subject for Type 1 diabetes (T1D) based on the expression levels of protein markers in a sample obtained from the subject. Additionally, this invention includes in vitro kits designed for use in these predictive methods. The second patent mirrors the first, emphasizing the importance of serum protein biomarkers in assessing diabetes risk.
Career Highlights
Harri Lähdesmäki is affiliated with Turun Yliopisto, where he continues to engage in research and development. His work is characterized by a commitment to improving diagnostic techniques and enhancing patient outcomes in diabetes care.
Collaborations
Lähdesmäki collaborates with esteemed colleagues, including Robert Moulder and Santosh Bhosale. These partnerships contribute to the innovative research environment that fosters advancements in medical technology.
Conclusion
Harri Lähdesmäki's contributions to diabetes risk prediction through his patents highlight his role as a key innovator in the medical field. His work not only advances scientific understanding but also has the potential to improve the lives of individuals at risk for type-1 diabetes.